• Profile
Close

Botulinum toxin-A for the treatment of neuralgia: A systematic review and meta-analysis

Journal of Pain Research Oct 19, 2018

Meng F, et al. - For neuralgia treatment, Researchers conducted a meta-analysis to assess the effectiveness and safety of botulinum toxin-A (BTX-A). Twelve randomized controlled trials (RCTs) comparing BTX-A treatment with saline for alleviating neuropathic pain were analyzed. At 4 weeks, the BTX-A group displayed significantly lower pain scores vs the saline group. BTX-A was not linked to any serious adverse events, but 14 out of 108 patients with trigeminal neuralgia experienced mild facial asymmetry after treatment with BTX-A. Findings thereby suggest that BTX-A could be a safe and effective treatment option for neuralgia.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay